Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in Inoperable Stage III NSCLC

Simple item page
dc.contributor.authorCalikusu, Z.
dc.contributor.authorUgurluer, G.
dc.contributor.authorSerin, M.
dc.contributor.authorSedef, A. M.
dc.contributor.authorMertsoylu, H.
dc.contributor.authorBesen, A.
dc.contributor.authorKose, F.
dc.date.accessioned2023-06-09T06:43:27Z
dc.date.available2023-06-09T06:43:27Z
dc.date.issued2017
dc.identifier.endpageS2303en_US
dc.identifier.issn1556-0864en_US
dc.identifier.issue11en_US
dc.identifier.startpageS2303en_US
dc.identifier.urihttp://hdl.handle.net/11727/9478
dc.identifier.volume12en_US
dc.identifier.wos000463860802302en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.jtho.2017.09.1705en_US
dc.relation.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectlung canceren_US
dc.subjectcarboplatin-paclitaxelen_US
dc.subjectChemoradiotherapyen_US
dc.titleConcurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in Inoperable Stage III NSCLCen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine